Of relevance, a recent study has shown that the overexpression of EZH2 may in fact be a consequence, rather than a cause of certain malignancies, and that whereas the high expression of EZH2 is correlated to poor prognosis in breast cancer, this association stands only when EZH2 expression couples to proliferation [147]. Here, EZH2 is linked to breast cancer.